Instrumento Inactivo

Otros idiomas Forma Therapeutics Holdings, Inc.

Acciones

FMTX

US34633R1041

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Novo Nordisk announces the completion of the Forma Therapeutics acquisition	17/10/22
Sector Update: Health Care Stocks Ending with Modest Declines	14/10/22
Sector Update: Health Care Stocks Sliding with Broader Friday Markets	14/10/22
Novo Nordisk Completes Acquisition of Forma Therapeutics; Forma Shares to be Delisted	14/10/22
Novo Nordisk : finalise l'acquisition de Forma Therapeutics	14/10/22
Novo Nordisk Completes Acquisition of Forma Therapeutics	14/10/22
FORMA THERAPEUTICS HOLDINGS, INC. : Termination of a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	14/10/22
Forma Therapeutics Holdings, Inc. Announces Board Changes	14/10/22
Forma Therapeutics Holdings, Inc.(NasdaqGM:FMTX) dropped from NASDAQ Composite Index	14/10/22
Forma Therapeutics Holdings, Inc.(NasdaqGM:FMTX) dropped from S&P Global BMI Index	14/10/22
Forma Therapeutics Holdings, Inc.(NasdaqGM:FMTX) dropped from S&P TMI Index	14/10/22
Forma Therapeutics Holdings, Inc.(NasdaqGM:FMTX) dropped from NASDAQ Biotechnology Index	13/10/22
Novo Nordisk A/S (CPSE:NOVO B) completed the acquisition of Forma Therapeutics Holdings, Inc. (NasdaqGM : FMTX) from RA Capital Management, L.P. and others.	13/10/22
Sickle Cell Disease Association of America & Partners Launch New PSA to Boost Awareness and Understanding of the Disease	30/09/22
FORMA THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX	27/09/22
Forma Therapeutics : Amendment to Initial Statement of Beneficial Ownership - Form 3/A	19/09/22
FORMA THERAPEUTICS INVESTOR ALERT by The Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Forma Therapeutics, Holdings Inc. - FMTX	02/09/22
Nvidia, Hormel fall; Nutanix, Forma Therapeutics rise	01/09/22
Top Midday Gainers	01/09/22
LATE BRIEFING - Unternehmen und Märkte -2-	01/09/22

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Forma Therapeutics Holdings, Inc.

Acciones

FMTX

US34633R1041

Otros idiomas

Filtros